Cells as advanced therapeutics: State-of-the-art, challenges, and opportunities in large scale biomanufacturing of high-quality cells for adoptive immunotherapies-Reference-Cited by-同舟云学术

Cells as advanced therapeutics: State-of-the-art, challenges, and opportunities in large scale biomanufacturing of high-quality cells for adoptive immunotherapies

Published:2017-05 Issue: Volume:114 Page:222-239
ISSN:0169-409X
Container-title:Advanced Drug Delivery Reviews
language:en
Short-container-title:Advanced Drug Delivery Reviews

Author:

Dwarshuis Nate J.,Parratt Kirsten,Santiago-Miranda Adriana,Roy Krishnendu

Funder

National Science Foundation

National Science Foundation Graduate Research Fellowship Program

Department of Defense National Defense Science and Engineering Graduate (NDSEG) Fellowship

NSF

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference173 articles.

1. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy;Rosenberg;Clin. Cancer Res.,2011

2. Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancer;Tran;Science,2014

3. HPV-targeted tumor-infiltrating lymphocytes for cervical cancer;Hinrichs,2014

4. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia;Kalos;Sci. Transl. Med.,2011

5. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias;Brentjens;Blood,2011

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An integrated perspective on measuring cytokines to inform CAR-T bioprocessing;Biotechnology Advances;2024-10

2. High throughput intracellular delivery by viscoelastic mechanoporation;Nature Communications;2024-01-02

3. Morphology-based deep learning approach for predicting adipogenic and osteogenic differentiation of human mesenchymal stem cells (hMSCs);Frontiers in Cell and Developmental Biology;2023-11-30

4. Mesenchymal stem cell secretome and extracellular vesicles for neurodegenerative diseases: Risk-benefit profile and next steps for the market access;Bioactive Materials;2023-11

5. Comparison of cell viability methods for human mesenchymal/stromal stem cells and human A549 lung carcinoma cells after freeze-thaw stress;Journal of Pharmacological and Toxicological Methods;2023-11